Immunotherapy for triple-negative breast cancer: combination strategies to improve outcome. Epidemiology of triple-negative breast cancer. Neighborhood social determinants of triple negative breast cancer. Survival study of triple-negative and non–triple-negative breast cancer in a Brazilian cohort. Triple-negative breast cancer: a brief review about epidemiology, risk factors, signaling pathways, treatment and role of artificial intelligence. You can learn more about how we ensure our content is accurate and current by reading our editorial policy. We link primary sources - including studies, scientific references, and statistics - within each article and also list them in the resources section at the bottom of our articles. Medical News Today has strict sourcing guidelines and draws only from peer-reviewed studies, academic research institutions, and medical journals and associations. As each person’s cancer is different, a doctor or oncologist can determine which treatment options are best for an individual. It indicated that a varied treatment protocol - including surgery, chemotherapy, and radiation - led to the best outcomes. However, according to a 2021 study, cancer recurrence rates are the same for those who had lumpectomy or removal of a lump and mastectomy. This treatment protocol can reduce an individual’s risk of recurrence and improve their survival rate. Therefore, doctors may recommend a mastectomy followed by radiation or chemotherapy. The average time it takes this type of breast cancer to recur is 19–40 months, compared to 35–67 months for other types of breast cancer. This means that if a person’s cancer has spread to other parts of the body, they may be more likely to have cancer that returns.ĭoctors consider triple-negative breast cancer more aggressive than other types of breast cancer. A 2018 Brazilian study found that in people with triple-negative breast cancer, cancers that had spread to the lymph nodes, were at later stages, or both, were associated with higher recurrence rates.Studies suggest that about 75% of recurrences happen within 3 years of diagnosis, and most occur within 5 years.Triple-negative breast cancer has higher recurrence rates than most other types of breast cancer, as follows:
0 kommentar(er)
